News in secondary care | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Sutimlimab approved in Europe for cold agglutinin haemolytic anaemia

Sutimlimab approved in Europe for cold agglutinin haemolytic anaemia

Review finds tixagevimab/cilgavimab effective for immunocompromised patients

Review finds tixagevimab/cilgavimab effective for immunocompromised patients

Nirsevimab approved for RSV in newborns and infants

Nirsevimab approved for RSV in newborns and infants

Study finds COVID-19 vaccine confidence declined since pandemic

Study finds COVID-19 vaccine confidence declined since pandemic

EMA recommends nirsevimab to protect infants from RSV

EMA recommends nirsevimab to protect infants from RSV

Alzheimer’s disease risk increased among patients with COVID-19

Alzheimer’s disease risk increased among patients with COVID-19

RCT finds dupilumab effective for children under six with atopic eczema

RCT finds dupilumab effective for children under six with atopic eczema

First oral NMDA receptor antagonist approved by FDA for major depression

First oral NMDA receptor antagonist approved by FDA for major depression

Bivalent COVID-19 booster vaccine approved by MHRA

Bivalent COVID-19 booster vaccine approved by MHRA

Launch of the Hospital Healthcare Europe Mobile App

Launch of the Hospital Healthcare Europe Mobile App

x